Tokyo Tape
Sign in
← Kawaguchi Chemical Industry

Quarterly report · Q2

4361.TEDINET S100OO05
Period2021-12-01 → 2022-05-31
Filed2022-07-11
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 46
MetricValuePeriodScopeSource row
Revenue¥3.9bn2021-12-01 → 2022-05-31Cons.Net sales
Revenue¥7.9bn2020-12-01 → 2021-11-30Cons.Net sales (5-year summary)
Revenue¥3.9bn2020-12-01 → 2021-05-31Cons.Net sales
Operating income¥226m2021-12-01 → 2022-05-31Cons.Operating income
Operating income¥270m2020-12-01 → 2021-05-31Cons.Operating income
Ordinary income¥235m2021-12-01 → 2022-05-31Cons.Ordinary income
Ordinary income¥386m2020-12-01 → 2021-11-30Cons.Ordinary income loss (5-year summary)
Ordinary income¥273m2020-12-01 → 2021-05-31Cons.Ordinary income
Profit before tax¥234m2021-12-01 → 2022-05-31Cons.Income before income taxes
Profit before tax¥273m2020-12-01 → 2021-05-31Cons.Income before income taxes
Net income (owners)¥179m2021-12-01 → 2022-05-31Cons.Profit loss attributable to owners of parent
Net income (owners)¥281m2020-12-01 → 2021-11-30Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥195m2020-12-01 → 2021-05-31Cons.Profit loss attributable to owners of parent
Net income¥179m2021-12-01 → 2022-05-31Cons.Profit loss
Net income¥195m2020-12-01 → 2021-05-31Cons.Profit loss
Total assets¥7.8bnat 2022-05-31Cons.Assets
Total assets¥7.9bnat 2021-11-30Cons.Assets
Total assets¥7.6bnat 2021-05-31Cons.Total assets (5-year summary)
Total liabilities¥5.4bnat 2022-05-31Cons.Liabilities
Total liabilities¥5.6bnat 2021-11-30Cons.Liabilities
Net assets / equity¥2.4bnat 2022-05-31Cons.Net assets
Net assets / equity¥2.3bnat 2021-11-30Cons.Net assets
Net assets / equity¥2.2bnat 2021-05-31Cons.Net assets (5-year summary)
Cash and deposits¥984mat 2022-05-31Cons.Cash and deposits
Cash and deposits¥1.3bnat 2021-11-30Cons.Cash and deposits
Cash & equivalents¥984mat 2022-05-31Cons.Cash and cash equivalents
Cash & equivalents¥1.3bnat 2021-11-30Cons.Cash and cash equivalents
Cash & equivalents¥1.1bnat 2021-05-31Cons.Cash and cash equivalents
Cash & equivalents¥883mat 2020-11-30dCons.Cash and cash equivalents
Operating cash flow−¥124m2021-12-01 → 2022-05-31Cons.Net cash provided by used in operating activities
Operating cash flow¥785m2020-12-01 → 2021-11-30Cons.Net cash provided by used in operating activities (5-year summary)
Operating cash flow¥388m2020-12-01 → 2021-05-31Cons.Net cash provided by used in operating activities
Investing cash flow−¥121m2021-12-01 → 2022-05-31Cons.Net cash provided by used in investment activities
Investing cash flow−¥246m2020-12-01 → 2021-11-30Cons.Net cash provided by used in investing activities (5-year summary)
Investing cash flow−¥109m2020-12-01 → 2021-05-31Cons.Net cash provided by used in investment activities
Financing cash flow−¥104m2021-12-01 → 2022-05-31Cons.Net cash provided by used in financing activities
Financing cash flow−¥119m2020-12-01 → 2021-11-30Cons.Net cash provided by used in financing activities (5-year summary)
Financing cash flow−¥78m2020-12-01 → 2021-05-31Cons.Net cash provided by used in financing activities
EPS (basic)¥147.062021-12-01 → 2022-05-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥68.822022-03-01 → 2022-05-31dCons.Basic earnings loss per share (5-year summary)
EPS (basic)¥230.992020-12-01 → 2021-11-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥160.32020-12-01 → 2021-05-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥95.622021-03-01 → 2021-05-31dCons.Basic earnings loss per share (5-year summary)
Equity ratio30.6%at 2022-05-31Cons.Equity to asset ratio (5-year summary)
Equity ratio28.5%at 2021-11-30Cons.Equity to asset ratio (5-year summary)
Equity ratio28.5%at 2021-05-31Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 18
SegmentItemPeriodValue
jpcrp040300-q2r_E01006-000Pharmaceutical Productsreportable segmentrevenue2021-12-01 → 2022-05-31¥3.9bn
jpcrp040300-q2r_E01006-000Pharmaceutical Productsreportable segmentrevenue external2021-12-01 → 2022-05-31¥3.9bn
jpcrp040300-q2r_E01006-000Pharmaceutical Productsreportable segmentsegment profit2021-12-01 → 2022-05-31¥211m
jpcrp040300-q2r_E01006-000Real Estate Leasingreportable segmentrevenue2021-12-01 → 2022-05-31¥19m
jpcrp040300-q2r_E01006-000Real Estate Leasingreportable segmentrevenue external2021-12-01 → 2022-05-31¥19m
jpcrp040300-q2r_E01006-000Real Estate Leasingreportable segmentsegment profit2021-12-01 → 2022-05-31¥15m
Total Of Reportable Segments And Otherssegment totalrevenue2021-12-01 → 2022-05-31¥3.9bn
Total Of Reportable Segments And Otherssegment totalrevenue external2021-12-01 → 2022-05-31¥3.9bn
Total Of Reportable Segments And Otherssegment totalsegment profit2021-12-01 → 2022-05-31¥226m
jpcrp040300-q2r_E01006-000Pharmaceutical Productsreportable segmentrevenue2020-12-01 → 2021-05-31¥3.9bn
jpcrp040300-q2r_E01006-000Pharmaceutical Productsreportable segmentrevenue external2020-12-01 → 2021-05-31¥3.9bn
jpcrp040300-q2r_E01006-000Pharmaceutical Productsreportable segmentsegment profit2020-12-01 → 2021-05-31¥255m
jpcrp040300-q2r_E01006-000Real Estate Leasingreportable segmentrevenue2020-12-01 → 2021-05-31¥19m
jpcrp040300-q2r_E01006-000Real Estate Leasingreportable segmentrevenue external2020-12-01 → 2021-05-31¥19m
jpcrp040300-q2r_E01006-000Real Estate Leasingreportable segmentsegment profit2020-12-01 → 2021-05-31¥15m
Total Of Reportable Segments And Otherssegment totalrevenue2020-12-01 → 2021-05-31¥3.9bn
Total Of Reportable Segments And Otherssegment totalrevenue external2020-12-01 → 2021-05-31¥3.9bn
Total Of Reportable Segments And Otherssegment totalsegment profit2020-12-01 → 2021-05-31¥270m

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 477
ItemContextValueUnit
Other caPrior1YearInstant53680000JPY
Other caCurrentQuarterInstant32276000JPY
Allowance for doubtful accounts caPrior1YearInstant-4356000JPY
Allowance for doubtful accounts caCurrentQuarterInstant-4267000JPY
Current assetsPrior1YearInstant5401683000JPY
Current assetsCurrentQuarterInstant5365265000JPY
Machinery equipment and vehicles netPrior1YearInstant1112209000JPY
Machinery equipment and vehicles netCurrentQuarterInstant1049785000JPY
Other net ppePrior1YearInstant1139743000JPY
Other net ppeCurrentQuarterInstant1134130000JPY
Property plant and equipmentPrior1YearInstant2251952000JPY
Property plant and equipmentCurrentQuarterInstant2183916000JPY
Other iaPrior1YearInstant13731000JPY
Other iaCurrentQuarterInstant18641000JPY
Intangible assetsPrior1YearInstant13731000JPY
Intangible assetsCurrentQuarterInstant18641000JPY
Other ioaPrior1YearInstant228213000JPY
Other ioaCurrentQuarterInstant214996000JPY
Allowance for doubtful accounts ioa by groupPrior1YearInstant-1300000JPY
Allowance for doubtful accounts ioa by groupCurrentQuarterInstant-1300000JPY
Investments and other assetsPrior1YearInstant226913000JPY
Investments and other assetsCurrentQuarterInstant213696000JPY
Noncurrent assetsPrior1YearInstant2492597000JPY
Noncurrent assetsCurrentQuarterInstant2416255000JPY
AssetsPrior1YearInstant7894280000JPY
AssetsCurrentQuarterInstant7781521000JPY
Notes and accounts payable tradePrior1YearInstant1297682000JPY
Notes and accounts payable tradeCurrentQuarterInstant1325687000JPY
Short term loans payablePrior1YearInstant1960000000JPY
Short term loans payableCurrentQuarterInstant1960000000JPY
Current portion of long term loans payablePrior1YearInstant573316000JPY
Current portion of long term loans payableCurrentQuarterInstant570774000JPY
Accounts payable otherPrior1YearInstant267602000JPY
Accounts payable otherCurrentQuarterInstant246003000JPY
Income taxes payablePrior1YearInstant89811000JPY
Income taxes payableCurrentQuarterInstant59024000JPY
Accrued consumption taxesPrior1YearInstant38468000JPY
Accrued consumption taxesCurrentQuarterInstant－JPY
Provision for directors bonusesPrior1YearInstant19800000JPY
Provision for directors bonusesCurrentQuarterInstant6000000JPY
Other clPrior1YearInstant288351000JPY
Other clCurrentQuarterInstant182692000JPY
Current liabilitiesPrior1YearInstant4535032000JPY
Current liabilitiesCurrentQuarterInstant4350181000JPY
Long term loans payablePrior1YearInstant580019000JPY
Long term loans payableCurrentQuarterInstant545903000JPY
Provision for directors retirement benefitsPrior1YearInstant125990000JPY
Provision for directors retirement benefitsCurrentQuarterInstant96840000JPY
Net defined benefit liabilityPrior1YearInstant274739000JPY
Net defined benefit liabilityCurrentQuarterInstant274482000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 14 of 14 passed
balance sheet identityconsolidated 2021-11-30pass
balance sheet identityconsolidated 2022-05-31pass rounding
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2021-11-30pass
statement vs summary · net assetsconsolidated 2022-05-31pass
statement vs summary · net income attributable to parentconsolidated 2020-12-01/2021-05-31pass
statement vs summary · net income attributable to parentconsolidated 2021-12-01/2022-05-31pass
statement vs summary · operating cash flowconsolidated 2020-12-01/2021-05-31pass
statement vs summary · operating cash flowconsolidated 2021-12-01/2022-05-31pass
statement vs summary · revenueconsolidated 2020-12-01/2021-05-31pass
statement vs summary · revenueconsolidated 2021-12-01/2022-05-31pass
statement vs summary · total assetsconsolidated 2021-11-30pass
statement vs summary · total assetsconsolidated 2022-05-31pass